All Stories

Dexcom wins FDA clearance for 15-day G7 CGM sensor

The new system, for people with Type 1 or Type 2 diabetes ages 18 and up, boosts wear time by 50% over the current G7 sensor.

Apr 10, 2025 - 16:40
 0
Dexcom wins FDA clearance for 15-day G7 CGM sensor
The new system, for people with Type 1 or Type 2 diabetes ages 18 and up, boosts wear time by 50% over the current G7 sensor.
Read More

Tags:

Previous Article

Tesla's Social Media Advertising Slides Into Edgelord Territory

Next Article

Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts

Related Posts

Fierce Biotech Fundraising Tracker '25: Neurona nabs $102M; Atsena adds $150M

Fierce Biotech Fundraising Tracker '25: Neurona nabs $1...

Apr 3, 2025  0

Sanofi's high hopes for $1.1B Kymab anti-inflammatory drug dented after phase 2 asthma failure

Sanofi's high hopes for $1.1B Kymab anti-inflammatory d...

Apr 15, 2025  0

Entrada’s 2-year ordeal ends as FDA lifts hold on DMD drug

Entrada’s 2-year ordeal ends as FDA lifts hold on DMD drug

Feb 24, 2025  0